FDA Finalizes Guidance on Product Name Placement in Advertisements

Drug Industry Daily
A A
The FDA finalized its guidance on drug advertisements, clarifying the legal requirements for companies in the placement of the product’s name — as well as its size, prominence and frequency in promotional labeling, and the juxtaposition between branded and active ingredient names.

To View This Article:

Login

Subscribe To Drug Industry Daily